SentinelOne, AeroVironment, PVH And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% points on Thursday.

Shares of SentinelOne, Inc.

fell sharply in today's pre-market trading following third-quarter results.

SentinelOne reported third-quarter revenue of $210.65 million, beating the consensus estimate of $209.72 million, according to Benzinga Pro.

Total revenue increased 28% year-over-year. Annualized recurring revenue (ARR) increased 29% to $859.7 million as of Oct. 31. Customers with ARR of $100,000 or more grew 24% to 1,310 in the quarter. The company ended the quarter with $1.1 billion in cash, cash equivalents and investments.

SentinelOne shares dipped 14.7% to $24.45 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

• nCino, Inc.
  NCNO-7.91%

  Get Free Report
  fell 18.7% to $34.50 in pre-market trading after the company reported third-quarter financial results and issued fourth-quarter revenue guidance below estimates.
• American Eagle Outfitters, Inc.
  AEO-14.5%

  Get Free Report
  fell 14.4% to $17.59 in today's pre-market trading after the company reported a year-over-year decrease in third-quarter sales results. Also, the company said it expects a 4% decrease in fourth-quarter total revenue.
• ZJK Industrial Co., Ltd.
  ZJK-16.4%

  + Free Alerts
  declined 14.3% to $11.70 in pre-market trading.
• KB Financial Group Inc.
  KB-9.82%

  + Free Alerts
  dropped 9.3% to $61.00 in pre-market trading.
• Synopsys, Inc.
  SNPS-10.6%

  Get Free Report
  dipped 8.4% to $538.60 in pre-market trading after the company issued first-quarter guidance below estimates.
• AeroVironment, Inc.
  AVAV-13.9%

  Get Free Report
  fell 8.1% to $181.04 in pre-market trading after the company announced quarterly financial results.
• PVH Corp.
  PVH+0.12%

  Get Free Report
  fell 7% to $105.00 in pre-market trading following third-quarter results.
• Mesoblast Limited
  MESO-2.40%

  + Free Alerts
  fell 6.4% to $10.72 in pre-market trading. The FDA granted Mesoblast’s Revascor Regenerative Medicine Advanced Therapy Designation in children with congenital heart disease.
• Rambus Inc
  RMBS-1.20%

  Get Free Report
  fell 3.8% to $56.71 in pre-market trading.

Now Read This:

• Dow Settles Above 45,000 For First Time As Salesforce, Marvell Surge: Investor Sentiment Improves, Fear Index In ‘Greed’ Zone